Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Ifsamide-M Injection

Prescription Icon
Prescription Required

Marketer

Gleason Healthcare

Salt Composition

Mesna (100mg) + Ifosfamide (1000mg)

Overview Ifsamide-M Injection

Ifsamide-M Injection, a prescription-only dual-agent cancer therapy, inhibits cancer cell proliferation and contributes to tumor regression. Administration must be overseen by a qualified healthcare provider; self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Common adverse effects include nausea, vomiting, alopecia, anemia (low red blood cell count), and leukopenia (low white blood cell count). Pre- and post-treatment blood tests may be required. Supplements may be prescribed to mitigate potential deficiencies. A diet rich in fruits and vegetables is also recommended. Disclose all other medications, pregnancy, breastfeeding status, and existing health conditions to your doctor. Alcohol consumption should be avoided during treatment. Operating machinery or driving is discouraged while using this medication.

Primary Ingredients of Ifsamide-M Injection

No text provided. Please provide the text you would like me to rephrase.

Uses of Ifsamide-M Injection

Malignant neoplasm

Major Benefits of Ifsamide-M Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Ifsamide-M Injection:

  • Hair loss
  • Nausea
  • Vomiting
  • Anemia (low number of red blood cells)
  • Blood in urine
  • Decreased white blood cell count
  • Increased risk of infection
  • Neurotoxicity

How to use Ifsamide-M Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Ifsamide-M Injection works:

Ifosfamide and Mesna, the components of Ifsamide-M Injection, act synergistically. Mesna, an anti-neoplastic agent, disrupts cancer cell DNA, hindering proliferation. Ifosfamide, a cytoprotective agent, mitigates the potential for Mesna-induced hemorrhagic cystitis.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Ifsamide-M Injection is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Ifsamide-M Injection during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in rare, life-threatening circumstances where potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Ifsamide-M Injection due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingUNSAFE

Administering Ifsamide-M Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Exercise caution when administering Ifsamide-M Injection to individuals with impaired renal function. Dosage modification of Ifsamide-M Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should receive Ifsamide-M Injection with careful monitoring. Dosage modification for Ifsamide-M Injection may be necessary. Physician consultation is advised.

What if you forget to take Ifsamide-M Injection :

Omit a dose of Ifsamide-M Injection? Seek your physician's advice.

Facts to Know About Ifsamide-M Injection

LabelValue
Developing Habits No.
Treatment Category Cancer Drugs
Ifsamide-M Injection
398
MRP 461
13% off